Muller Lorenz
Chief Commercial Officer
Muller Lorenz has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.
On the most recent filing, Muller Lorenz is listed as Chief Commercial Officer at Milestone Pharmaceuticals Inc. Inside the rolling window, Muller Lorenz reported no open-market purchases and 2 open-market sales totaling $146K in MIST. The largest disclosed transaction in the window is a sale of 53,566 MIST shares on Dec 15, 2025, worth $124K.
Companies traded
Other insiders at MIST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$146K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Muller Lorenz made?
Muller Lorenz has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Muller Lorenz trade?
Muller Lorenz has filed SEC Form 4 disclosures for 1 company, including MIST.
When was Muller Lorenz's most recent SEC Form 4 filing?
Muller Lorenz's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.
What is Muller Lorenz's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Muller Lorenz is listed as Chief Commercial Officer.
What is Muller Lorenz's total buy and sell value in the current window?
Inside the rolling retention window, Muller Lorenz bought $0 and sold $146K based on SEC Form 4 filings.
What was Muller Lorenz's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 53,566 MIST shares on 2025-12-15, worth $124K, per SEC Form 4 filings.